Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05935748
Title Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NiKang Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego RECRUITING La Jolla California 92093 United States Details
Northwestern University - Feinberg School of Medicine RECRUITING Chicago Illinois 60611 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of Michigan-Rogel Cancer Center RECRUITING Ann Arbor Michigan 48109 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065-6094 United States Details
UT Southwestern Medical Center RECRUITING Dallas Texas 75390-9324 United States Details
University of Virginia Health System RECRUITING Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field